Regenxbio Inc (RGNX)

EBITDA

-$139.12M

TTM · Period ending: · USD

RGNX logo

RGNX EBITDA

Latest reported-$139.12M
RGNX TTM EBITDA ($778.00K → -$139.12M)
High-resolution chart · PNG

RGNX ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regenxbio Inc EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-139,117,000
-229,349,000
-133,255,000
-119,997,000
-129,927,000
-122,443,000
-198,228,000
-217,825,000
-218,881,000
-236,898,000
-239,464,000
-233,663,000
-243,772,000
-235,942,000
-244,242,000
123,832,000
140,945,000
150,549,000
177,088,000
-177,066,000
-117,234,000
-100,292,000
-96,832,000
-97,611,000
-142,605,000
-145,598,000
-141,846,000
-99,684,000
-87,438,000
-45,069,000
92,082,000
72,446,000
73,627,000
52,028,000
-73,199,000
-77,087,000
-74,992,000
-75,535,000
-64,370,000
-50,069,000
-38,880,000
-30,265,000
-19,060,000
-13,616,000
-6,322,000
-41,000
778,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.